Wild Bioscience has raised $60 million in a Series A round led by the EIT, alongside Oxford Science Enterprises (OSE), Braavos Capital, and the Uni Oxford.
01 October 2025
01 October 2025
Total investments received (USD): 60M
Round value (USD): 60M
Company: Wild Bioscience
Related deals
Chemify raised $50 million Series B round led by Insight Partners and Wing.
Investments
10 October 2025
Comind to raise $60M series B led by Plural, joined by Angelini, LocalGlobe, Octopus Ventures, Crane Venture Partners, BACKED VC and Entrepreneurs First.
Investments
09 October 2025
Elevara Medicines raised $70m in Series A funding led by Forbion and Sofinnova Partners, joined by insiders Monograph Capital and Weatherden.
Investments
02 October 2025
Trogenix raised €80m in Series A led by IQ Capital, joined by 4Bio, Cancer Research Horizons, Brain Tumour Fund, Eli Lilly, Meltwind, LongeVC and Calculus
Investments
01 October 2025
Omnea raised $50m in Series B funding co-led by Insight Partners and Khosla Ventures, joined by Accel, Point Nine, First Round Capital, and Prosus.
Investments
05 September 2025
Belgium
Austria
Switzerland
Denmark
Estonia
Finland
Iceland
Lithuania
Norway
Sweden
Ireland
Portugal
Spain